Shanghai Biopharmaleader co.,ltd

If you are going to consult the information about 288383-20-0 from one of the leading 288383-20-0 manufacturers and suppliers in China,Website:://.biopharmaleader.net, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.288383-20-0 Product NameCediranibSynonymsAZD-2171FormulaC25H27FN4O3Molecular Weight450.51Spec / Purity98%minSupply CapacityDetailsCediranib (AZD-2171) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. On 8 March 2010, AstraZeneca issued a press-release stating that cediranib had failed Phase III clinical trials for use in first-line metastatic colorectal cancer when it was compared clinically with the market-leader bevacizumab. As of November 2012, it was being assessed in double-blind studies for the treatment of methylated Glioblastoma Multiforme at the University of Washington Medical Center.